Stockscreener 앱 받기
80.07
0.45%
0.36
시간 외 거래:
79.95
-0.12
-0.15%
전일 마감가:
$79.71
열려 있는:
$78.99
하루 거래량:
8.56M
Relative Volume:
1.60
시가총액:
$33.57B
수익:
$9.51B
순이익/손실:
$2.64B
주가수익비율:
13.27
EPS:
6.0361
순현금흐름:
$2.14B
1주 성능:
+6.08%
1개월 성능:
-32.25%
6개월 성능:
-34.40%
1년 성능:
-50.40%
1일 변동 폭
$76.21
$80.42
1주일 범위
$72.38
$80.44
52주 변동 폭
$72.38
$172.23
조에티스 Stock (ZTS) Company Profile
명칭
Zoetis Inc
전화
973-822-7000
주소
10 SYLVAN WAY, PARSIPPANY, NJ
Compare ZTS vs TAK, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
80.07 | 33.42B | 9.51B | 2.64B | 2.14B | 6.0361 |
TAK
Takeda Pharmaceutical Co Adr
|
16.48 | 52.70B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.32 | 41.10B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.16 | 39.96B | 17.53B | 1.58B | 444.18M | 1.3457 |
UTHR
United Therapeutics Corp
|
565.87 | 23.94B | 3.17B | 1.29B | 1.01B | 27.09 |
조에티스 Stock (ZTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-12 | 재확인 | Stifel | Buy |
| 2023-12-19 | 재개 | Jefferies | Buy |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | 개시 | Atlantic Equities | Overweight |
| 2020-08-14 | 업그레이드 | Edward Jones | Hold → Buy |
| 2020-08-12 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2020-05-27 | 개시 | Jefferies | Buy |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-09-09 | 개시 | Goldman | Buy |
| 2019-07-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | 개시 | Barclays | Overweight |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2019-05-03 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-03-04 | 업그레이드 | Stifel | Hold → Buy |
| 2019-01-23 | 개시 | UBS | Neutral |
| 2018-10-15 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-08-03 | 재확인 | Stifel | Buy |
| 2018-04-19 | 재확인 | Citigroup | Buy |
| 2018-03-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | 재확인 | Stifel | Buy |
| 2018-01-04 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
조에티스 주식(ZTS)의 최신 뉴스
Return on invested capital % of Zoetis, Inc. Class A – BVL:ZTSUS - TradingView
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zoetis Inc.ZTS - PR Newswire
Total liabilities & shareholders' equities of Zoetis, Inc. Class A – BVL:ZTSUS - TradingView
Zoetis, Inc. Class A Cash Flow – BVL:ZTSUS - TradingView
Asset turnover of Zoetis, Inc. Class A – BVL:ZTSUS - TradingView
Zoetis Inc. (ZTS) to Attend Investor Conferences Amidst Challenging Market Conditions - GuruFocus
Zoetis Probe Tests Guidance Credibility And Long Term Investor Confidence - Yahoo Finance
Can Zoetis Face NYSE Composite Pressure After Guidance Review? - Kalkine Media
Levi & Korsinsky Announces Investigation of Securities Claims Against Zoetis (ZTS) - GlobeNewswire Inc.
Zoetis to Participate in Upcoming Investor Conferences - The Joplin Globe
Zoetis Faces Fraud Probe As Burry Backs Dividend-Paying Animal Health Firm - simplywall.st
Zoetis (ZTS) Declares Quarterly Dividend Amid Revised Revenue Ou - GuruFocus
What's Driving Zoetis's Recent Volatility and Dividend Appeal - Kavout
Zoetis Inc. (ZTS) Announces Third Quarter Dividend for 2026 - GuruFocus
Insiders and Institutions Snap Up Zoetis Shares at Steep Discount as US Pet Sales Slump - AD HOC NEWS
Zoetis Declares Third-Quarter 2026 Cash Dividend - TipRanks
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Zoetis Inc. stock rises Wednesday, still underperforms market - MarketWatch
Zoetis Keeps Quarterly Dividend at $0.53 per Share, Payable Sept. 1 to Holders of Record July 20 - marketscreener.com
Zoetis declares $0.53 quarterly dividend payable Sept. 1, record date July 20 - TradingView
Zoetis declares $0.53 quarterly dividend, payable Sept. 1 By Investing.com - Investing.com Canada
Zoetis (ZTS) Board approves $0.53 per-share dividend for Q3 2026 - Stock Titan
Zoetis Declares Third Quarter 2026 Dividend - The Joplin Globe
Press Release: Zoetis Declares Third Quarter 2026 Dividend - Moomoo
Zoetis Q1 earnings lag estimates, 2026 view cut, stock down - MSN
ZTS Investor Alert: Levi & Korsinsky Investigates Zoetis (ZTS) for Potential Securities Fraud - Morningstar
Zoetis Stock Pulls Back to Support – Smart Entry? - Trefis
Barclays (DJP) prices Zoetis‑linked Notes with 13.20% digital payout - Stock Titan
Zoetis Stock Near Crucial SupportBuy Signal? - Trefis
Zoetis shares plunge 21.5% after cutting 2026 revenue guidance and missing Q1 results. - Pluang
Bronstein, Gewirtz & Grossman, LLC Is Investigating Zoetis, Inc. (ZTS) And Encourages Stockholders to Connect - The National Law Review
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
New FDA Authorization Broadens Zoetis Screwworm Treatment Options - Successful Farming
A Look At Zoetis (ZTS) Valuation After Soft Q1 Results And Lower 2026 Guidance - simplywall.st
Zoetis Inc (NYSE:ZTS): A Dividend Growth Stock with Strong Profitability and Attractive Valuation - ChartMill
Zoetis Inc (ZTS) Shares Surge 4.7% -- What GF Score of 83 Tells Investors - GuruFocus
Zoetis Price Target Cut to $112.00/Share From $145.00 by Citigroup - Moomoo
Zoetis: Reducing Our Fair Value Estimate, but Shares Remain Undervalued - Morningstar
FinancialContentZoetis Inc. (ZTS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - FinancialContent
Zoetis' Wide Moat Remains Intact, but We've Lowered Our Fair Value Estimate - Morningstar
Citigroup Adjusts Price Target on Zoetis to $112 From $145, Maintains Buy Rating - Moomoo
ZTS Stock Price, Quote & Chart | ZOETIS INC (NYSE:ZTS) - ChartMill
Why Zoetis (ZTS) Is Down 10.4% After Trimming 2026 Outlook Amid Weaker Pet Demand - simplywall.st
Zoetis Inc. stock underperforms Monday when compared to competitors - MSN
5 Revealing Analyst Questions From Zoetis’s Q1 Earnings Call - Yahoo Finance
Stoneridge Investment Partners LLC Makes New Investment in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. $ZTS Shares Sold by Saratoga Research & Investment Management - MarketBeat
Zoetis Inc. $ZTS Shares Bought by Canada Post Corp Registered Pension Plan - MarketBeat
(ZTS) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Zoetis Drops to 52-Week Low, Monday Open in Focus - TechStock²
Zoetis Stock at Support Zone – Bargain or Trap? - Trefis
조에티스 (ZTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
0.43%
자본화:
|
볼륨(24시간):